Gara Jalqabaatti › Myelodysplastic Syndromes › Missouri › Kansas City
Qorannoo klinikaalii Myelodysplastic Syndromes Kansas City, MO keessatti
Qorannoo 7 Myelodysplastic Syndromes f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- fi 1 dabalataa
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · Miili 5 fagaatti
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners P.A. MidAmerica Cancer Care, Kansas City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Mercy Hospitals and Clinics, Kansas City
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Namoota walitti qabaa jiraSadarkaa 3
- MidAmerica Cancer Care, Kansas City
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas Cancer Center, Westwood · Miili 5 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Kansas City
Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti
- Houston, TXQorannoo 43
- Baldwin Park, CAQorannoo 26
- New York City, NYQorannoo 21
- Seattle, WAQorannoo 21
- Washington, DCQorannoo 20
- Tampa, FLQorannoo 19
- Boston, MAQorannoo 19
- Miami, FLQorannoo 17
- Durham, NCQorannoo 14
- Columbus, OHQorannoo 14
- St. Louis, MOQorannoo 13
- Atlanta, GAQorannoo 13
Qorannoo biroo Kansas City keessatti
- Saree OljooQorannoo 34
- Kansara Qara'a Non-Small CellQorannoo 31
- Cufama OnneeQorannoo 25
- Saree (Gosoota Hunda)Qorannoo 21
- Dhibee QaraQorannoo 19
- Kansarii ColorectalQorannoo 16
- Kansara MetastatikiiQorannoo 15
- Leukemia Myeloidii HamaaQorannoo 15
- Kansarii ProstateQorannoo 14
- Kansarii OvariiQorannoo 11
- ObesityQorannoo 11
- Sukkaraa Gosa 2Qorannoo 11
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.